{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:30:34Z","timestamp":1790620234963,"version":"4.1.0"},"reference-count":62,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Center","doi-asserted-by":"publisher","award":["NCN-UMO-14\/15\/01019"],"award-info":[{"award-number":["NCN-UMO-14\/15\/01019"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Background: Cognitive disorders associated with schizophrenia are closely linked to prefrontal cortex (PFC) dysfunction. Administration of the non-competitive NMDA receptor antagonist ketamine (KET) induces cognitive impairment in animals, producing effects similar to those observed in schizophrenic patients. In a previous study, we showed that KET (20 mg\/kg) induces cognitive deficits in mice and that administration of clozapine (CLZ) reverses this effect. To identify biochemical mechanisms related to CLZ actions in the context of KET-induced impairment, we performed a biochemical analysis using the same experimental paradigm\u2014acute and sub-chronic administration of these drugs (0.3 and 1 mg\/kg). Methods: Since the effect of CLZ mainly depends on G-protein-related receptors, we used the Signaling PathwayFinder Kit to identify 84 genes involved in GPCR-related signal transduction and then verified the genes that were statistically significantly different on a larger group of mice using RT-PCR and Western blot analyses after the administration of acute and sub-chronic drugs. Results: Of the 84 genes involved in GPCR-related signal transduction, the expression of six, \u03b2arrestin1, \u03b2arrestin2, galanin receptor 2 (GalR2), dopamine receptor 2 (DRD2), metabotropic glutamate receptor 1 (mGluR1), and metabotropic glutamate receptor 5 (mGluR5), was significantly altered. Since these genes affect the levels of other signaling proteins, e.g., extracellular signal-regulated kinase 1\/2 (ERK1\/2), G protein-coupled receptor kinase 2 (Grk2), and G protein-gated inwardly rectifying potassium 3 (Girk3), we determined their levels in PFC using Western blot. Most of the observed changes occurred after acute treatment with 0.3 mg\/kg CLZ. We showed that acute treatment with CLZ at a lower dose significantly increased \u03b2arrestin1 and ERK1\/2. KET treatment induced the upregulation of \u03b2arrestin1. Joint administration of these drugs had no effect on the \u03b2arrestin1 level. Conclusion: The screening kit we used to study the expression of GPCR-related signal transduction allowed us to select several important genes affected by CLZ. However, the obtained data do not explain the mechanism of action of CLZ that is responsible for reversing KET-induced cognitive impairment.<\/jats:p>","DOI":"10.3390\/ijms222212203","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T23:02:41Z","timestamp":1636671761000},"page":"12203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of Molecular Markers of Clozapine Action in Ketamine-Induced Cognitive Impairment: A GPCR Signaling PathwayFinder Study"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8926-3143","authenticated-orcid":false,"given":"Agata","family":"Korlatowicz","sequence":"first","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Ku\u015bmider","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Szlachta","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Pabian","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7818-4263","authenticated-orcid":false,"given":"Joanna","family":"Solich","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dziedzicka-Wasylewska","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-190X","authenticated-orcid":false,"given":"Agata","family":"Faron-G\u00f3recka","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemical Pharmacology, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Sm\u0119tna Street 12, 31-343 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0019-5545.31613","article-title":"Cognitive deficits in psychiatric disorders: Current status","volume":"48","author":"Trivedi","year":"2006","journal-title":"Indian J. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bandc.2008.01.006","article-title":"On the historical and conceptual background of the Wisconsin Card Sorting Test","volume":"67","author":"Eling","year":"2008","journal-title":"Brain Cogn."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neubiorev.2010.01.012","article-title":"Assessing cognitive function in clinical trials of schizophrenia","volume":"34","author":"Barnett","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","article-title":"Medial frontal cortex mediates perceptual attentional set shifting in the rat","volume":"20","author":"Birrell","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00213-017-4613-x","article-title":"Effect of clozapine on ketamine-induced deficits in attentional set shift task in mice","volume":"234","author":"Szlachta","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2018.00040","article-title":"Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex","volume":"11","author":"Szlachta","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.euroneuro.2008.05.001","article-title":"The role of D1-D2 receptor hetero-dimerization in the mechanism of action of clozapine","volume":"18","author":"Wasylewski","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2011.03.038","article-title":"Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor","volume":"659","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jnc.13582","article-title":"Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics\u2014In vitro studies","volume":"137","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejmech.2014.02.058","article-title":"Novel insights on the structural determinants of clozapine and olanzapine multitarget binding profiles","volume":"22","author":"Selent","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","first-page":"319","article-title":"Desensitization of G protein-coupled receptors","volume":"51","author":"Freedman","year":"1996","journal-title":"Recent Prog. Horm. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1083\/jcb.148.6.1267","article-title":"Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1\/2","volume":"148","author":"DeFea","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1073\/pnas.041604898","article-title":"Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds","volume":"98","author":"Luttrell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","first-page":"162","article-title":"Animal models of schizophrenia","volume":"64","author":"Jones","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.euroneuro.2013.09.011","article-title":"Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans","volume":"24","author":"Neill","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shallice, T. (1988). From neuropsychology to Mental Structure, Cambridge University Press.","DOI":"10.1017\/CBO9780511526817"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0278-5846(99)00064-0","article-title":"Effect of amphetamine, alpha-methyl-p-tyrosine (alpha-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats","volume":"23","author":"Lahti","year":"1999","journal-title":"Prog. Neuro. Psychopharmacol. Biol. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0924-977X(96)00039-9","article-title":"Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biopsych.2013.05.021","article-title":"The ultimate intra-\/extra-dimensional attentional set-shifting task for mice","volume":"75","author":"Scheggia","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","article-title":"Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia. Test of predictive validity","volume":"28","author":"Becker","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2007.12.029","article-title":"A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats","volume":"16","author":"McLean","year":"2008","journal-title":"Behav. Brain Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00213-010-2102-6","article-title":"The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice","volume":"214","author":"Kos","year":"2011","journal-title":"Psychopharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nikiforuk, A., Kos, T., Fija\u0142, K., Ho\u0142uj, M., Rafa, D., and Popik, P. (2013). Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0066695"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.bcp.2004.02.017","article-title":"Inverse agonist properties of atypical antipsychotic drugs","volume":"67","author":"Akam","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","article-title":"Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist","volume":"315","author":"Burstein","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors-implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mehy.2005.01.035","article-title":"Does clozapine work by blocking spikes and sparing bursts?","volume":"65","author":"Olson","year":"2005","journal-title":"Med. Hypotheses"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuroscience.2011.05.015","article-title":"Galanin receptor 2 overexpressing mice display an antidepressive-like phenotype: Possible involvement of the subiculum","volume":"190","author":"Xia","year":"2011","journal-title":"Neuroscience"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2008.06.068","article-title":"Antidepressants reverse theattenuation of the neurotrophic MEK\/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation","volume":"56","author":"Qi","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1152\/jn.2002.87.5.2324","article-title":"Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex","volume":"87","author":"Chen","year":"2002","journal-title":"J. Neurophysiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-010-1954-0","article-title":"Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole","volume":"212","author":"Iasevoli","year":"2010","journal-title":"Psychopharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2013.01.018","article-title":"Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment","volume":"146","author":"Matosin","year":"2013","journal-title":"Schizophr. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2006.10.004","article-title":"AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs","volume":"90","author":"Muly","year":"2007","journal-title":"Schizophr. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41380-018-0234-y","article-title":"mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1074\/jbc.M209626200","article-title":"Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination","volume":"278","author":"Shenoy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neubiorev.2012.12.005","article-title":"Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia","volume":"37","author":"Matosin","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1007\/s00018-019-03274-3","article-title":"G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub","volume":"76","author":"Penela","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.0409534102","article-title":"Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor","volume":"102","author":"Ren","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.molcel.2006.11.007","article-title":"New roles for beta-arrestins in cell signaling: Not just for seven-transmembrane receptors","volume":"24","author":"Lefkowitz","year":"2006","journal-title":"Mol Cell."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41467-017-02661-3","article-title":"Lack of beta-arrestin signaling in the absence of active G proteins","volume":"9","author":"Grundmann","year":"2018","journal-title":"Nat Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2010.10.018","article-title":"Nonenzymatic rapid control of GIRK channel function by a G protein-coupled receptor kinase","volume":"143","author":"Raveh","year":"2010","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.euroneuro.2017.02.005","article-title":"Clozapine as the most efficacious antipsychotic for activating ERK 1\/2 kinases: Role of 5-HT2A receptor agonism","volume":"27","author":"Aringhieri","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2004.12.002","article-title":"Clozapine and the mitogen-activated protein kinase signal transduction pathway: Implications for antipsychotic actions","volume":"57","author":"Browning","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/jpet.107.131987","article-title":"Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation","volume":"325","author":"Ahmed","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12031-009-9188-5","article-title":"Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor","volume":"39","author":"Pereira","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","article-title":"Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test","volume":"279","author":"Li","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"134292","DOI":"10.1016\/j.neulet.2019.134292","article-title":"Clozapine administered repeatedly following pretreatment with ketamine enhances dopamine D2 receptors in the dopamine mesolimbic pathway in mice brain","volume":"707","author":"Szlachta","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein-coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","article-title":"Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice","volume":"23","author":"Bohn","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.RES.81.6.1021","article-title":"beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation","volume":"81","author":"Conner","year":"1997","journal-title":"Circ. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neulet.2006.02.071","article-title":"Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray","volume":"400","author":"Jiang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrn2834","article-title":"Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease","volume":"11","author":"Slesinger","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/bs.irn.2015.05.016","article-title":"Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction","volume":"123","author":"Mayfield","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/sj.npp.1300100","article-title":"Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice","volume":"28","author":"Morgan","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1601-183X.2008.00388.x","article-title":"Behavioral characterization of mice lacking GIRK\/Kir3 channel subunits","volume":"7","author":"Pravetoni","year":"2008","journal-title":"Genes Brain Behav."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Rame, M., Caudal, D., Schenker, E., Svenningsson, P., Spedding, M., Jay, T.M., and Godsil, B.P. (2017). Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177036"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:28:35Z","timestamp":1760167715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":62,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222212203"],"URL":"https:\/\/doi.org\/10.3390\/ijms222212203","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]}}}